Your browser doesn't support javascript.
loading
Highly Selective Y4 Receptor Antagonist Binds in an Allosteric Binding Pocket.
Schüß, Corinna; Vu, Oanh; Schubert, Mario; Du, Yu; Mishra, Nigam M; Tough, Iain R; Stichel, Jan; Weaver, C David; Emmitte, Kyle A; Cox, Helen M; Meiler, Jens; Beck-Sickinger, Annette G.
Affiliation
  • Schüß C; Institute of Biochemistry, Leipzig University, Leipzig 04103, Germany.
  • Vu O; Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37235, United States.
  • Schubert M; Institute of Biochemistry, Leipzig University, Leipzig 04103, Germany.
  • Du Y; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Mishra NM; Department of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas 76107, United States.
  • Tough IR; King's College London, Wolfson Centre for Age-Related Diseases, Institute of Psychiatry, Psychology & Neuroscience, London SE1 1UL, U.K.
  • Stichel J; Institute of Biochemistry, Leipzig University, Leipzig 04103, Germany.
  • Weaver CD; Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37235, United States.
  • Emmitte KA; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Cox HM; Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Meiler J; Department of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas 76107, United States.
  • Beck-Sickinger AG; King's College London, Wolfson Centre for Age-Related Diseases, Institute of Psychiatry, Psychology & Neuroscience, London SE1 1UL, U.K.
J Med Chem ; 64(5): 2801-2814, 2021 03 11.
Article in En | MEDLINE | ID: mdl-33595306
Human neuropeptide Y receptors (Y1R, Y2R, Y4R, and Y5R) belong to the superfamily of G protein-coupled receptors and play an important role in the regulation of food intake and energy metabolism. We identified and characterized the first selective Y4R allosteric antagonist (S)-VU0637120, an important step toward validating Y receptors as therapeutic targets for metabolic diseases. To obtain insight into the antagonistic mechanism of (S)-VU0637120, we conducted a variety of in vitro, ex vivo, and in silico studies. These studies revealed that (S)-VU0637120 selectively inhibits native Y4R function and binds in an allosteric site located below the binding pocket of the endogenous ligand pancreatic polypeptide in the core of the Y4R transmembrane domains. Taken together, our studies provide a first-of-its-kind tool for probing Y4R function and improve the general understanding of allosteric modulation, ultimately contributing to the rational development of allosteric modulators for peptide-activated G protein-coupled receptors (GPCRs).
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Receptors, Neuropeptide Y / Benzothiazoles Limits: Animals / Humans Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2021 Document type: Article Affiliation country: Germany Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Receptors, Neuropeptide Y / Benzothiazoles Limits: Animals / Humans Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2021 Document type: Article Affiliation country: Germany Country of publication: United States